Canton Hathaway’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Canton Hathaway’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.18M	Buy	7,475 +830	+12%	+$131K	0.23%	50
2026 Q2	$1.05M	Hold	6,645	–	–	0.2%	62
2026 Q1	$849K	Hold	6,645	–	–	0.17%	66
2025 Q4	$810K	Hold	6,645	–	–	0.16%	66
2025 Q3	$666K	Sell	6,645 -450	-6%	-$40.5K	0.13%	78
2025 Q2	$588K	Sell	7,095 -1,750	-20%	-$140K	0.12%	81
2025 Q1	$717K	Sell	8,845 -8,415	-49%	-$752K	0.14%	66
2024 Q4	$1.55M	Sell	17,260 -1,685	-9%	-$163K	0.39%	34
2024 Q3	$1.87M	Buy	18,945 +1,310	+7%	+$129K	0.47%	29
2024 Q2	$1.64M	Buy	17,635 +4,060	+30%	+$364K	0.45%	32
2024 Q1	$1.29M	Buy	+13,575	New	+$1.26M	0.35%	37
2022 Q3	–	Sell	-300	Closed	-$22K	–	262
2022 Q2	$22K	Buy	+300	New	+$22.5K	0.01%	242
2022 Q1	–	Sell	-300	Closed	-$34K	–	296
2021 Q4	$34K	Sell	300 -50	-14%	-$6.03K	0.01%	226
2021 Q3	$44K	Hold	350	–	–	0.01%	195
2021 Q2	$47K	Hold	350	–	–	0.01%	166
2021 Q1	$47K	Hold	350	–	–	0.02%	165
2020 Q4	$49K	Hold	350	–	–	0.02%	169
2020 Q3	$39K	Hold	350	–	–	0.02%	241
2020 Q2	$39K	Hold	350	–	–	0.03%	114
2020 Q1	$27K	Hold	350	–	–	0.02%	117
2019 Q4	$33K	Hold	350	–	–	0.02%	147
2019 Q3	$27K	Hold	350	–	–	0.02%	157
2019 Q2	$31K	Hold	350	–	–	0.02%	151
2019 Q1	$31K	Hold	350	–	–	0.02%	152
2018 Q4	$25K	Hold	350	–	–	0.02%	133
2018 Q3	$34K	Buy	+350	New	+$33.9K	0.02%	114

Other funds holding XBI

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Employees Retirement System of Texas Austin, Texas $12.2B AUM 27.55% 1-Year Est. Return

Investure LLC Charlottesville, Virginia $1.83B AUM 14.32% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Canton Hathaway's XBI Position: Q3 2026 in Review

Canton Hathaway increased its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q3 2026, buying an estimated $131K and bringing the position to 7,475 shares worth $1.18M. The position accounts for 0.23% of the portfolio, ranked #50.

Canton Hathaway first reported a position in XBI in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.87M in Q3 2024. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Canton Hathaway held 7,475 shares of State Street SPDR S&P Biotech ETF worth $1.18M as of Q3 2026.
Canton Hathaway bought 830 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $131K.
State Street SPDR S&P Biotech ETF made up 0.23% of Canton Hathaway's portfolio in Q3 2026, its #50 holding.
Canton Hathaway first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 26 quarters since.
Canton Hathaway's State Street SPDR S&P Biotech ETF position peaked at $1.87M in Q3 2024.
604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.